GI
BIO icon

GAMMA Investing’s Bio-Rad Laboratories Class A BIO Stock Holding History

GAMMA Investing’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$526K Buy
1,393
+285
+26% +$99.5K 0.02% 679
2026
Q2 		$325K Sell
1,108
-139
-11% -$39.4K 0.01% 910
2026
Q1 		$348K Buy
1,247
+122
+11% +$35.1K 0.02% 758
2025
Q4 		$341K Buy
1,125
+138
+14% +$43.1K 0.02% 705
2025
Q3 		$277K Buy
987
+253
+34% +$68.8K 0.02% 768
2025
Q2 		$177K Buy
734
+127
+21% +$30K 0.01% 999
2025
Q1 		$148K Sell
607
-58
-9% -$17.4K 0.01% 945
2024
Q4 		$218K Buy
665
+130
+24% +$44.1K 0.02% 646
2024
Q3 		$179K Buy
535
+214
+67% +$68K 0.02% 673
2024
Q2 		$87.7K Buy
321
+87
+37% +$25.3K 0.01% 849
2024
Q1 		$80.9K Buy
234
+104
+80% +$34.2K 0.02% 745
2023
Q4 		$41.8K Buy
+130
New +$40.7K 0.01% 1008

Other funds holding BIO

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

GAMMA Investing's BIO Position: Q3 2026 in Review

GAMMA Investing increased its Bio-Rad Laboratories Class A (BIO) stake by 26% in Q3 2026, buying an estimated $99.5K and bringing the position to 1,393 shares worth $526K. The position accounts for 0.02% of the portfolio, ranked #679.

GAMMA Investing first reported a position in BIO in Q4 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • GAMMA Investing held 1,393 shares of Bio-Rad Laboratories Class A worth $526K as of Q3 2026.
  • GAMMA Investing bought 285 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $99.5K.
  • Bio-Rad Laboratories Class A made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #679 holding.
  • GAMMA Investing first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.